Wednesday, August 26, 2026

Fixed Income Trading

2 articles

30-Year Treasury Yields Breach 5% as Bond Markets Flash Global Fiscal Warning

30-Year Treasury Yields Breach 5% as Bond Markets Flash Global Fiscal Warning

30-year U.S. Treasury yields have broken above 5% and UK gilt yields have hit their highest levels since the 1990s, signaling a synchronized global bond market selloff. Persistent inflation driven by the Iran conflict and tariff uncertainty—compounding $857 in added annual gasoline costs for American households—is colliding with record sovereign debt loads and an impending Fed leadership transition. Diplomatic progress from the Trump-Xi summit and U.S.-China tariff reductions provides partial re

LM Salvado
Treasury 30-Year Yields Cross 5%, UK Gilts Hit 1990s Highs — The Bond Revolt Traders Must Watch

Treasury 30-Year Yields Cross 5%, UK Gilts Hit 1990s Highs — The Bond Revolt Traders Must Watch

30-year Treasury yields have crossed 5% and UK gilts are trading at levels last seen in the 1990s, signaling a structural inflation regime rather than a cyclical episode. CPI holds at 3.8% with services inflation above 3% annually, compounded by the Iran war adding $857 to Americans' average gasoline costs in 2026. Jerome Powell's departure has created a Fed leadership vacuum that amplifies market uncertainty at the worst possible moment.

LM Salvado
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com